1H-Indene-2-methanol, 2,3-dihydro-2,5-dimethyl-
Common Name: |
1H-Indene-2-methanol, 2,3-dihydro-2,5-dimethyl- |
IUPAC Name: |
(2,5-dimethyl-1,3-dihydroinden-2-yl)methanol |
Molecular Formula: |
C7H12O2 |
SMILES: |
CC1=CC2=C(CC(C2)(C)CO)C=C1 |
Inchi: |
1S/C12H16O/c1-9-3-4-10-6-12(2,8-13)7-11(10)5-9/h3-5,13H,6-8H2,1-2H3 |
Inchi Key: |
UWSPWQQZFOSTHS-UHFFFAOYSA-N |
Cas No: |
285977-85-7 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
2 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
128.17 |
Mass (g/mol) |
176.12 |
Molar Refractivity |
34.93 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
2 |
Rings |
2 |
TPSA |
26.30 |
Hetero Atoms |
1 |
Heavy Atoms |
9 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
280.00 to 281.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.002 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.86 |
LogP |
2.092 |
iLOGP |
1.84 |
XLOGP3 |
1.10 |
WLOGP |
1.49 |
MLOGP |
1.23 |
ESOL Log S |
-1.20 |
ESOL Solubility (mg/ml) |
8.17 |
ESOL Solubility (mol/l) |
0.064 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.24 |
Ali Solubility (mg/ml) |
7.29 |
Ali Solubility (mol/l) |
0.06 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-1.54 |
Silicos-IT Solubility (mg/ml) |
3.65 |
Silicos-IT Solubility (mol/l) |
0.03 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.30 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.83 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.636 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |